Nutex Health (NUTX) Tops Q2 EPS by 450c

Nutex Health (NASDAQ: NUTX) reported Q2 EPS of $9.38, $4.50 better than the analyst estimate of $4.88. Revenue for the quarter came in at $210.75 million versus the consensus estimate of $214.99 million.

For earnings history and earnings-related data on Nutex Health (NUTX) click here.

You May Also Be Interested In

• Barrick Is Said to Weigh Delaying North America Gold IPO to 2027 - Bloomberg
• Yatsen Holding (YSG) Reports Q2 Loss of $0.16
• FuelCell Energy (FCEL) Misses Q3 EPS by 24c